These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19767151)

  • 1. High-grade glioma mouse models and their applicability for preclinical testing.
    de Vries NA; Beijnen JH; van Tellingen O
    Cancer Treat Rev; 2009 Dec; 35(8):714-23. PubMed ID: 19767151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for high-grade gliomas.
    Galanis E; Buckner J
    Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
    McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
    Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
    Friedman HS
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide in malignant gliomas.
    Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of high-grade astrocytoma.
    Sathornsumetee S; Rich JN; Reardon DA
    Neurol Clin; 2007 Nov; 25(4):1111-39, x. PubMed ID: 17964028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glioma therapy up-date].
    de la Fuente BP; Dalmau J; Rosenfeld M
    Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
    Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
    Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
    Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
    Siker ML; Chakravarti A; Mehta MP
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological diagnosis of gliomas by genotype analysis].
    Nakamura M; Shimada K; Nakase H; Konishi N
    Brain Nerve; 2009 Jul; 61(7):773-80. PubMed ID: 19618854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of glioma.
    Stylli SS; Luwor RB; Ware TM; Tan F; Kaye AH
    J Clin Neurosci; 2015 Apr; 22(4):619-26. PubMed ID: 25698543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.